Brought to you by 
Ciba-Geigy and Sandoz merged in $27 billion deal
Mar 1996
Executive Summary
Ciba-Giegy and Sandoz merged creating the number 2 drug company (behind Glaxo Wellcome) in a $27 billion stock swap. The combined company called Novartis will have estimated annual sales of $27.27bn (36bn Swiss francs) in 1997.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Stock
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ciba-Geigy and Sandoz merged in $27 billion deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice